![Matthew Foehr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Foehr
Chief Executive Officer at
OMNIAB, INC.
Net worth: 16 M $ as of 2026-06-29
Profile
Matthew William Foehr is President, Chief Executive Officer & Director at OmniAb Operations, Inc. and OmniAb, Inc. since 2022.
He is Director at The Pelican, Inc. since 2020, Director at Ligand UK Group Ltd. since 2018, and Independent Director at Viking Therapeutics, Inc. since 2014.
Former roles include Independent Director at Ritter Pharmaceuticals, Inc. from 2015 to 2020; Director at Ligand UK Ltd. from 2018 to 2022; President & Chief Operating Officer at Ligand Pharmaceuticals, Inc. from 2015 to 2022; Senior Vice President-Technical Operations at Connetics Corp.
from 1999 to 2006; Senior VP-Global Research & Development Operations at Stiefel Laboratories, Inc. from 2009 to 2011; and Chief Scientific Officer-Dermatology & VP at GlaxoSmithKline LLC from 2010 to 2011.
Education includes undergraduate studies at Santa Clara University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
OMNIAB, INC. 3.05% | 2026-04-22 | 4,420,492 ( 3.05% ) | 11 M $ | 2026-06-29 |
| 2026-03-14 | 132,036 ( 0.11% ) | 5 M $ | 2026-06-29 |
Matthew Foehr active positions
| Companies | Position | Start |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Director/Board Member | 2014-04-30 |
| PFENEX INC. | Director/Board Member | 2020-09-30 |
| OMNIAB, INC. | Chief Executive Officer | 2022-10-31 |
Ligand UK Group Ltd.
 Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | 2018-10-11 |
OmniAb Operations, Inc.
 OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Chief Executive Officer | 2022-10-31 |
Former positions of Matthew Foehr
| Companies | Position | End |
|---|---|---|
Ligand UK Research Ltd.
 Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | 2024-03-18 |
| VERNALIS | Director/Board Member | 2022-10-31 |
| LIGAND PHARMACEUTICALS INCORPORATED | President | 2021-12-31 |
| AIXCRYPTO HOLDINGS, INC. | Director/Board Member | 2020-04-30 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Matthew Foehr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Ligand UK Ltd.
 Ligand UK Ltd. BiotechnologyHealth Technology Engages in research and development & sells pharmaceutical products | Health Technology |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Develops and commercializes dermatology products | Health Technology |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of therapeutic treatments for gastrointestinal diseases and conditions | Health Technology |
Ligand UK Research Ltd.
Ligand UK Research Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Santa Clara University
 Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Pelican Inc
 Pelican Inc Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical therapeutics and vaccines | Health Technology |
Ligand UK Group Ltd.
Ligand UK Group Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
OmniAb Operations, Inc.
OmniAb Operations, Inc. BiotechnologyHealth Technology Develops drug discovery platform | Health Technology |
OmniAb, Inc.
 OmniAb, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
- Stock Market
- Insiders
- Matthew Foehr
